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Protein–membranes interactionA change in the conformational plasticity of a-Synuclein (a-Syn) is hypothesised to be a key step in
the pathogenic mechanism of Parkinson’s disease (PD). Here, we report the study of extracellular a-
Syn interaction with whole cells and membranes isolated from the neuronal SH-SY5Y cells,
exploiting NMR and CD spectroscopies. In addition, the crosslinking agent DSG was used to freeze
the conformational and oligomeric state of a-Syn in the presence of cells. These data, in a
quasi-physiological environment, conﬁrm the protein monomeric state with a propensity to adopt
a transient alpha helical following interaction with biological membranes.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
a-Synuclein (a-Syn) is a 140-residue protein that is highly
expressed in the central nervous system and is the major con-
stituent of Lewy bodies (LBs), the pathological hallmark of Parkin-
son’s disease (PD) [1].
The protein can be subdivided in three main regions according
to its primary sequence: (1) the N-terminal region (1–60) known to
interact with lipid vesicles [2], and including the well-conserved,
imperfect KTKEGV repeats; (2) the hydrophobic NAC (non-
amyloid–b component) region (aa 61–95) responsible for protein
aggregation [3] and (3) the negatively charged C-terminal region,
spanning amino acids 96–140, which plays an important role in
counteracting the aggregation [4].
a-Syn is mainly detected as a cytosolic protein, nonetheless a
portion of it is recovered bound to membranes. In particular it is
suggested that binding to membrane phospholipids controls a-
Syn structure, physiology and pathogenesis [5]. It is well known
that a-Syn has a preference to bind highly curved, negatively
charged membranes that incorporate synaptic vesicle lipids [6].Following the loss of membrane curvature generated from the
endocytosis of neurotransmitter, a-Syn is likely induced to dissoci-
ate from the membrane into the cytosol [6,7].
a-Syn exists predominantly as disordered monomeric protein
prone to associate with negative charged small unilamellar vesicles
(SUVs) in order to adopt essentially helical conformation in aqueous
solution [6,8]. The presence of a-Syn as a disordered monomeric
form has been widely reported in different cellular systems[1]. In
detail, as reported in Fusco et al. [9], the N-terminal alpha helix
(residues 6–25) seems to act as an anchor to the membrane and is
only marginally affected by lipid composition while the region
26–97 results to act as a membrane ‘‘sensor’’ modulating the
strength of the interactions in a lipid-speciﬁc manner. Available
NMR/EPR structures of a-Syn on micelles are indicative of a
monomeric horseshoe-like broken-helix conformation [10]. Other
techniques, on the other hand, suggest that a-Syn monomers adopt
an extended helical structure in the membrane [10].
In addition, aSyn has long been thought to occur normally as a
natively unfolded monomer of 14.5 kDa [11,12] deﬁned as a hub
protein because involved in several interactions with many part-
ners, representing a crucial node in different pathways. A debate
has recently begun over its oligomeric state [11] focusing the dis-
cussion on the existence of a-Syn as a putative alpha helical tetra-
mer as physiologically relevant protein structure [13,14] or as a
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troscopy has been used to observe directly the structure and the
dynamics of this protein within Escherichia coli cells [15] revealing
still another time a disordered monomeric form as that present in
aqueous solution.
Despite being a cytosolic protein, a small amount of a-Syn has
been detected in human plasma and cerebrospinal ﬂuid [16]. This
form, released by a non-classical exocytosis, seems to represent a
physiological event that could designate extracellular Syn as a
biomarker for related diseases [17]. In this study, to get further
insight into a-Syn structure when bound to cellular membranes,
circular dichroism, NMR spectroscopy and confocal microscopy
have been used to characterise a-Syn conformational behaviour,
not only in the presence of intact neuronal cells SH-SY5Y, a cellular
system widely used to study PD [18], but also of membranes
obtained from the same cells. In addition, the oligomeric state of
a-Syn was monitored in the presence of cells by using the
crosslinking agent DSG.
2. Materials and methods
2.1. Expression and puriﬁcation of a-Syn and TAT-a-Syn
Recombinant a-Syn and TAT-a-Syn were expressed and puriﬁed
from periplasmic space content as reported in Caldinelli et al. [19].
The pET5a-a-Syn plasmid was a gift of Prof. Bartels (Boston, Mas-
sachusetts, United states of America). The recombinant protein
was expressed and puriﬁed according to the procedure previously
reported [20].
For NMR studies, cell cultures were growth in aminimummedia
containing Na2HPO4 6 g/L, KH2PO4 3 g/L, NaCl 0.5 g/L and 15NH4Cl
1 g/L completed adding MgSO4 1 mM, Thiamine hydrochloride
1 mM, CaCl2 0.1 mM and Glucose 0.2% [21]. Protein expression
and puriﬁcation protocols for 15N labelled samples have been per-
formed as previously reported [19,22]. The purity of all the proteins
was evaluated by using 15% SDS–PAGE. The molecular mass was
analysed by ESI-Quadrupole mass spectroscopy. For NMR experi-
ments proteins were extensively dialyzed against PBS at pH 7.4.
2.2. Cell culture and membrane recovery
SH-SY5Y cells (ATCC, USA) were grown in DMEM supplemented
with 10% fetal bovin serum (FBS), 1% glutamine, 100 U/mL peni-
cillin and 100 lg/mL streptomycin (Euroclone, MI, Italy), at 37 C
in a humidiﬁed atmosphere with 5% CO2. The viability of the cells
was checked by Trypan blue reactive after each CD and NMR
experiment.
Membranes used in NMR experiments were isolated from SH-
SY5Ycells. Cells were detached from the ﬂask with trypsin and
washed twice with phosphate buffered saline. Then the cells were
transferred into homogenisation buffer containing PBS and homo-
genised by means of a pellet pestle (Sigma). Particulate matter was
removed by centrifuging at 2500 rpm for 15 min. The supernatant
was then centrifuged at 28000 rpm for 1 h at 4 C. The pellet was
washed and centrifuged at 28000 rpm for 30 min at 4 C. 200 ll
of PBS was added to the pellet, and the membrane was resuspend-
ed by 20 passages through a 25 gauge needle.
2.3. Confocal microscopy analyses of a-Syn and TAT-a-Syn in presence
of SH-SY5Y cells
15 lM of a-Syn and TAT-a-Syn were labelled with Fluorescein
isothiocyanate (FITC, Sigma). The reaction was conducted in PBS
pH 7.4 with a tenfold molar excess of FITC for 16 h at 4 C in slow
agitation. The excess of FITC was removed by extensive dialysis at
4 C in PBS. FITC-labelled-a-Syn and FITC-labelled-TAT-a-Syn(15 lM) were incubated with 105 SH-SY5Y cells on a 35 mm glass
bottom dishes (P35G-1.5-10-C Case, MatTek corporation) 16 h at
37 C in a humidiﬁed atmosphere with 5% CO2 [23]. Thereafter,
the cells were washed in PBS and analysed with confocal
microscopy. The confocal images were acquired using a Leica TCS
SP5 Confocal Laser Scanning Microscopy (CLSM) (Leica Microsys-
tems, Wetzlar, Germany). Leica Application Suite software was
used for confocal images processing.
2.4. Circular dichroism studies
CD spectra ofa-Synwere recordedwith a J-810 spectropolarime-
ter equippedwith a Peltier temperature control system (Model PTC-
423-S, Jasco Europe, Cremella, LC, Italy). Far-ultraviolet (far-UV)
measurements (195–260 nm) were carried out at 20 C using a
0.1 cm optical path length cell and a protein concentration of
15 lM. CD spectra, recorded with a time constant of 4 s, a 2 nm
bandwidth, and a scan rate of 10 nmmin1, were signal-averaged
over at last three scans. The baseline was corrected by subtracting
the complete buffer spectrum.
CD spectra in the presence of SH-SY5Y cells were registered
using 3  105 cells in PBS buffer. In this case the baseline was cor-
rected by subtracting the spectrum of the cells alone at the same
time of incubation. All CD experiments were performed in the
same experimental conditions using the recombinant a-Syn with-
out any tag.
Further CD spectra were performed after 16 h of incubation at
room temperature in the presence of cells and adding a 25-fold
molar excess of DSG (Di(N-succinimidyl) glutarate, Sigma Aldrich)
[24]. The reaction mixture was incubated at room temperature for
30 min. Finally the reaction was quenched for 15 min using 25 mM
Tris Base. The samples were centrifuged at 1200 rpm for 5 min to
remove cells and were loaded onto a Superdex 200 gel ﬁltration
column (HiLoad 10/30; GE Healthcare Bio-Sciences AB, Uppsala,
Sweden) pre-equilibrated with PBS (pH 7.4). The peak, eluted at
14 ml, was recovered and analysed by CD.
MREs (deg dmol1 cm2) were calculated using the equations
previously reported [25].
2.5. NMR sample preparation and analyses
NMR data were collected on a Varian INOVA 600-MHz NMR
spectrometer equipped with a cold-probe and at room tem-
perature. 2D [1H–15N] heteronuclear single quantum coherence
(HSQC) correlation spectra were acquired by using a fast version
of sensitivity enhanced HSQC pulse-sequence. Data were collected
using a spectral width of 5400 Hz with 1024 complex points in
the direct dimension and a spectral width of 1600-Hz with 64 com-
plex points in the nitrogen dimension. Data were processed using
Sparky (Goddard, T.D.; Kneller, D.G., SPARKY 3. University of California:
San Francisco.) and analysed using Neasy, a tool of CARA soft-
ware.[26] Intensity ratios were computed as I0  I/I0, where I0 is
the signal intensity in the reference spectra and I is the intensity
in the presence of whole cells or of isolated membranes.
The 15N relaxation parameters R1, R2 and [1H–15N] NOE were
determined at 600 MHz. 15N R1 data were collected using relax-
ation delay times in the following order (in seconds): 0.01, 0.05,
0.09, 0.36, 0.73, 1.01, 1.31, 1.80. 15N R2 data were measured using
a pulse sequence employing a CPMG (Carr Purcell Meiboom Gill)
pulse train [27] and the relaxation delays (in seconds) were 0.01,
0.03, 0.05, 0.07, 0.09, 0.13, 0.17, 0.21, 0.25. {1H–15N} steady state
NOE values are reported as the ratio of peak heights in paired spec-
tra collected with and without an initial period (4s) of proton
saturation during the 5-s recycle delay.
NMR samples were prepared in a ﬁnal volume of 500uL. For
natural membrane interaction analyses 15N-labelled a-Syn
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SY5Y cells as previously reported [22]. Further experiments were
conducted on 15N-labelled a-Syn (150 lM) after incubation of
16 h at room temperature in the presence of 3  106 SH-SY5Y
intact cells.
3. Results
3.1. Expression and puriﬁcation of a-Syn and TAT-a-Syn
a-Syn and TAT-a-Syn were expressed and puriﬁed as elsewhere
described [19]. The periplasmic contents were loaded onto a Ni–
NTA afﬁnity column (GE Healthcare, USA) and the recombinant
proteins were eluted increasing imidazole concentration
(300 mM). The proteins was obtained in an homogenous form as
shown by SDS–PAGE and the yield of the proteins was respectively
15 mg/L for a-Syn and 10 mg/L for TAT-a-Syn.
For further experiments, proteins were extensively dialyzed
against PBS buffer (pH 7.4).
3.2. a-Syn characterisation in the presence of intact cells
a-Syn CD spectrum is typical of an intrinsically disordered pro-
tein with a negative peak at 198 nm (Fig. 1). 15 lM of a-Syn was
incubated with 3  105 SH-SY5Y cells in PBS buffer at pH 7.4 andFig. 1. (A) Far-UV CD spectra of a-Syn in the presence of whole SH-SY5Y cells at differe
alone at the same time of incubation. (B) a-helix relative percentage. Data are the meanCD spectra were recorded at different time of incubation (Fig. 1A
and B). Even if a partial structuring is observed already after one
hour of incubation, an increase up to about 15% in alpha helix,
characterised by two negative bands at 208 and 222 nm in the
CD spectrum, occurs after 16 h incubation. The same results were
obtained also with the untagged protein: this demonstrating that
the His-tag at the N-terminus did not affect the conformational
modiﬁcation in the presence of the cells. Confocal microscopy
results, in which FITC-labelled-a-Syn and FITC-labelled-TAT-a-
Syn were incubated with SH-SY5Y cells (Fig. 2), demonstrate that
in our experimental conditions a-Syn (lacking the TAT transport
sequence) does not cross the cellular membrane to a signiﬁcant
extent, i.e. an uptake is apparent for the TAT-a-Syn only following
a 16 h of incubation with SH-SY5Y cells. Similarly, CD data of a-Syn
incubated with SH-SY5Y cells are representative of a protein pre-
sent on the surface of cytoplasmic membrane (Fig. 3). In addition
a-Syn was incubated with SH-SY5Y cells and after 16 h of incuba-
tion at RT a speciﬁc lysine crosslinking, di(N-succinimidyl) glu-
tarate (DSG), was added. After removing cells by centrifugation,
samples were loaded onto a Superdex 200 gel ﬁltration column
pre-equilibrated with PBS (pH 7.4) and the peak with a retention
time of 14 mL was collected and analysed by CD spectroscopy.
As shown in Fig. 3 a-Syn, after incubation with cells and addition
of DSG, retains an alpha helical conformation of about 15%. Never-
theless a-Syn in presence of SH-SY5Y, without the crosslinkingnt time of incubation. Data were obtained by subtracting the spectrum of the cells
of three different measurements.
Fig. 2. Uptake of SH-SY5Y cells incubated at 37 C in a humidiﬁed atmosphere with 5% CO2 with TAT-a-Syn (A–C) and a-Syn (D–F) for 16 h. Fluorescence (A and D),
transmitted light (B and E) and merge (C and F) images. Magniﬁcation bar: 20 lm.
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than 5% a-helix (Fig. 3A and B). This structuration is underlined
by the gel permeation proﬁle showing a more compact form for
a-Syn when compared with the protein no treated with DSG that
presents a retention time of 15.1 ml versus 14.2 mL (Fig. 3C).
In addition, SDS–PAGE analysis of a-Syn samples treated with
DSG in the presence or not of cells indicated a role of the crosslink-
ing in stabilizing the monomeric form of a-Syn only due to the
interaction with SH-SY5Y membranes (Fig. 3D).
3.3. NMR results
The structural switch of a-Syn from the free to membrane
bound state has been examined by NMR spectroscopy in presence
of whole living neuronal cells and in presence of isolated natural
membranes.
Under these conditions, the a-Syn backbone resonances were
identiﬁed and assigned by comparison with spectra of the protein
in aqueous solution. Fig. S1 shows a selected region of the 2D
[1H–15N] HSQC spectra under different experimental conditions;
intensities of several resonances are strongly reduced both in the
presence of whole cells (Fig. S1A) and isolated membranes
(Fig. S1B), indicating a-syn interaction to the cellular membranes.
Indeed, in the presence of whole cells the average a-Syn amide
signal intensity (Fig. 4A) displays signiﬁcant broadening effects
over most of the sequence, particularly in the N-terminal domain
(residues 1–100) of the protein. Within the N-terminal lipid bind-
ing region of the protein three distinct regions, encompassing
amino acids from D2 to K12, from S42 to V55 and from V71 to
K80, undergo the highest signal attenuations. A much smaller
broadening effect is observed for residues in the C-terminal region,
except for those included between S129 and Y136.
To further investigate the a-Syn transition to membrane
bound state, the NMR experiments have been performed by using
isolated cellular membranes. As showed in Fig. 4B, the regionsmost affected upon interaction with the isolated cellular mem-
branes correspond to those identiﬁed in the presence of intact
cells.
Furthermore, a-Syn backbone dynamics was explored in pres-
ence of isolated membranes, by measuring 15N relaxation rate con-
stants R1 and R2 and heteronuclear {1H–15N} steady state NOEs.
The relaxation data, shown in Fig. S2, indicate that a-Syn backbone
dynamics is quite uniformly rigid throughout the N-terminal lipid-
binding domain of the protein. On the other hand, a high degree of
ﬂexibility of the C-terminal tail is clearly evidenced by both
{1H–15N} NOE and R2 and to a lesser extent by R1 values. Three dis-
tinct regions, encompassing M5-A11, G47-A56, T72-V77, exhibit
signiﬁcant R2 increases.
4. Discussion
a-Syn is a versatile protein, presenting different states i.e.
cytosolic, membrane-bound and aggregated forms [9]. It has been
shown to be an intrinsically disordered protein [12] in different
conditions, nonetheless in other environments further plausible
oligomeric structured form have been hypothesised [13]. The
membrane-associated state of a-Syn, in equilibrium with its
cytosolic form, has been widely studied because it results to play
a key role in the physiology and in PD insurgence [28]. Literature
data strongly suggest that the bound state is regulated by different
properties such as the curvature and charge but it is not affected by
the compositions [9,29].
In the last years it is emerging a relevant role also for the extra-
cellular form of a-Syn as demonstrated by the proinﬂammatory
responses of glial cells [30,31] following the treatment with extra-
cellular a-Syn. Therefore, extracellular a-Syn may have signiﬁcant
implications in pathogenesis resulting in all three major patho-
logical features of neurodegenerative disease, namely protein
aggregates, neurodegeneration, and neuroinﬂammation [17]. Thus,
the release of a-Syn is a physiological event, which also contributes
Fig. 3. (A) Far-UV CD spectra of puriﬁed a-Syn after 16 h incubation at room temperature in the presence of SH-SY5Y cells and the addition of DSG. (B) a-helix relative
percentage. Data are the mean of three different measurements. (C) Superdex S200 10/30 analyses of a-Syn incubated with SH-SY5Y cells and treated with DSG, after removal
of the cells. (D) SDS–PAGE analyses of a-Syn incubated with DSG in the presence of SH-SY5Y cells. Lane (1) a-Syn; lane (2) molecular weight marker; lane (3) a-Syn treated
with DSG; lane (4) supernatant of SH-SY5Y treated with DSG; lane (5) a-Syn incubated 16 h with SH-SY5Y cells and treated with DSG, after removal of the cells.
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Syn as a biomarker for related diseases [17].
Very recently an exchange of a-Syn between the brain and
peripheral tissues has been demonstrated being able to cross the
blood–brain-barrier (BBB). In this context this study focuses on
the conformational plasticity of the extracellular a-Syn form in
the presence of neuronal whole cells and their isolated mem-
branes. SH-SY5Y cells [18] are used to analyse the propensity of
a-Syn to increase its a-helical content. Our data well corroborated
with the observation, obtained both using whole cells and isolated
membranes, that lipid bilayers determine an a-Syn’s conforma-
tional equilibrium towards structural states preferentially in a-he-
lices, as clearly indicated by CD results. Furthermore, the NMR
characterisation identiﬁes the N-terminal lipid binding region of
the protein as that involved in the interaction with membrane
phospholipids. In particular, regions encompassing amino acids
from D2 to K12, from S42 to V55 and from V71 to K80 are indicated
as major players in the membrane recognition, likely folded as
helices upon membrane interaction. Accordingly, the three a-syn
regions above identiﬁed are characterised by a more rigid back-
bone dynamics within the N-terminal region that is globally much
less ﬂexible than a-syn C-terminus.
Similar results have been observed for a-Syn in the presence of
model membrane systems [32,33]. In the presence of SH-SY5Y cells,
the CD-estimated percentage of alpha-helix results to be smaller
whether compared to that determined in other systems (15% versus
60%) [29], but it is in agreement with the extent of a-syn residues
mostly involved in membrane interaction, as determined by theNMR chemical shift perturbation data. Such differences in helical
content of a-syn upon membrane interaction could be ascribed to
the heterogeneous composition of cellular membranes respect to
artiﬁcial model membranes used [5,20]. In addition, the use of the
crosslinking agent DSG has allowed to freeze the conformational
and oligomeric state of a-Syn in the presence of cells, further con-
ﬁrming the protein monomeric state with a propensity to adopt
an alpha helical conformation as showed in CD spectra. This confor-
mation is lost after the removal of the cells suggesting that a-Syn
assumes an alpha helical conformation to interact with SH-SY5Y
cells and it returns to be a disordered protein in its membrane free
state. a-Syn binds to the cytoplasmic membrane in its unstructured
conformation and its content in a-helix increases following interac-
tion with the phospholipids.
Overall, NMR characterisation ofa-syn binding towhole cells and
to isolatedmembranes showed similar results that can be easily inte-
grated. Whole cells represent a simple and suitable handle system
but they bear some disadvantages such as being labile and less
homogeneous when compared to the isolated membranes. At the
same time, isolated membranes, extracted by the same cells, allow
longer experimental investigations, such NMR relaxation analysis,
and hamper possible cell internalisation of membrane ligands and
therefore can provide further structural details in deﬁning mem-
brane binding modes of extracellular molecular partners.
Altogether our results corroborate the hypothesis that, as a typi-
cal IDP, upon binding with membranes, a-Syn retains a certain
degree of ﬂexibility [34] and does not assume considerable amounts
of secondary structures.
Fig. 4. (A) Intensity ratios for all a-Syn residues (I0  I/I0P 0.45 ± 0.21) extracted from 2D [15N, 1H] HSQC experiments performed in SH-SY5Y suspension. (B) Intensity ratios
for all a-Syn residues (I0  I/I0P 0.40 ± 0.18) extracted from 2D [15N, 1H] HSQC experiments performed in the presence of isolated natural membranes.
G. Smaldone et al. / FEBS Letters 589 (2015) 798–804 803Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2015.02.
012.
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